Hi jembers! I think we have to be practical regarding the Holidays. I'm in sales and prospecting new customers around Christmas time is difficult. It's possible to close deals that were started before, but often people say get back with me after the New Year because they are in shut down mode.

So I see this LymPro Launch in three phases: 1) ICON Validation Announcement, (today) 2) LP002 Data announced (Next Monday), & 3) LymPro commitments (Early January).

I think the news today is giving shareholders the signal that we are on track. In the PR he promised to deliver data by year end, and so he is getting us through the Holidays and preparing the way for bigger things in January: LymPro sales and Retintis Orphan approval.

I say we hit .20 cents by February 1st and we up list by March 1st.